Workflow
辅酶Q10系列
icon
Search documents
金达威跌2.04%,成交额1.45亿元,主力资金净流出1164.80万元
Xin Lang Cai Jing· 2025-09-18 06:47
Core Viewpoint - The stock of Kingdawei has experienced fluctuations, with a recent decline of 2.04% on September 18, 2023, while the company has shown a year-to-date increase of 30.61% in stock price [1] Financial Performance - For the first half of 2025, Kingdawei reported a revenue of 1.728 billion yuan, representing a year-on-year growth of 13.46%, and a net profit attributable to shareholders of 247 million yuan, which is a significant increase of 90.12% [2] - Cumulatively, since its A-share listing, Kingdawei has distributed a total of 2.761 billion yuan in dividends, with 488 million yuan distributed over the past three years [3] Shareholder Information - As of June 30, 2025, the number of shareholders for Kingdawei is 40,700, a decrease of 4.30% from the previous period, while the average circulating shares per person increased by 4.50% to 14,976 shares [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 1.5915 million shares, and Southern CSI 1000 ETF, which increased its holdings by 521,500 shares [3] Market Activity - On September 18, 2023, Kingdawei's stock price was 19.20 yuan per share, with a trading volume of 145 million yuan and a turnover rate of 1.22%, resulting in a total market capitalization of 11.711 billion yuan [1] - The net outflow of main funds was 11.648 million yuan, with significant selling pressure observed in large orders [1] Business Overview - Kingdawei, established on November 24, 1997, and listed on October 28, 2011, is primarily engaged in the manufacturing of health food and nutritional products, with its main revenue sources being health food (54.57%), coenzyme Q10 series (22.04%), and vitamin A series (11.41%) [1] - The company is classified under the food and beverage industry, specifically in food processing and health products [1]
金达威9月11日获融资买入2249.98万元,融资余额4.44亿元
Xin Lang Zheng Quan· 2025-09-12 01:27
Core Insights - On September 11, Jindawei's stock fell by 0.25% with a trading volume of 184 million yuan [1] - As of September 11, the total margin balance for Jindawei was 444 million yuan, which is 3.70% of its circulating market value, indicating a high level of margin financing [1] - For the first half of 2025, Jindawei reported a revenue of 1.728 billion yuan, a year-on-year increase of 13.46%, and a net profit attributable to shareholders of 247 million yuan, up 90.12% year-on-year [2] Financing and Margin Trading - On September 11, Jindawei had a margin buy amount of 22.4998 million yuan and a margin repayment of 23.7208 million yuan, resulting in a net margin buy of -1.2210 million yuan [1] - The margin balance of 444 million yuan is above the 70th percentile of the past year, indicating a relatively high level of margin trading activity [1] - The short selling data shows that on September 11, Jindawei had a short repayment of 15,600 shares and a short sale of 1,300 shares, with a short balance of 22,000 shares, which is below the 20th percentile of the past year [1] Shareholder and Institutional Holdings - As of June 30, 2025, Jindawei had 40,700 shareholders, a decrease of 4.30% from the previous period, while the average circulating shares per person increased by 4.50% to 14,976 shares [2] - The total cash dividends distributed by Jindawei since its A-share listing amount to 2.761 billion yuan, with 488 million yuan distributed in the last three years [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the fourth largest with 6.9372 million shares, an increase of 1.5915 million shares from the previous period [2]